financetom
Business
financetom
/
Business
/
Studio City Q2 revenue up 17.7%, narrows net loss
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Studio City Q2 revenue up 17.7%, narrows net loss
Jul 31, 2025 5:34 AM

Overview

* Studio City Q2 revenue rises to $190.1 mln, driven by mass market operations

* Adjusted EBITDA for Q2 increases to $76.4 mln, reflecting revenue growth

* Net loss narrows to $3.7 mln from $33.4 mln in Q2 2024

Result Drivers

* MASS MARKET OPERATIONS - Improved performance in mass market operations drove revenue increase, per company

* CASINO CONTRACT REVENUE - Revenue from casino contract rose to $83.8 mln, attributed to strategic repositioning

* NON-GAMING REVENUES - Higher overall non-gaming revenues contributed to revenue growth

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 $190.10

Revenue mln

Q2 Net -$3.70

Income mln

Q2 $76.40

Adjusted mln

EBITDA

Q2 Capex $16.30

mln

Q2 $23.10

Operatin mln

g Income

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Osisko Development to Resume Activities at Cariboo Project in British Columbia After Wildfires
Osisko Development to Resume Activities at Cariboo Project in British Columbia After Wildfires
Jul 26, 2024
07:36 AM EDT, 07/26/2024 (MT Newswires) -- Osisko Development ( ODV ) said on Friday that it will resume activities at the Cariboo gold project in British Columbia after authorities lifted a wildfire evacuation order. The wildfires didn't affect mine site infrastructure and all access roads to the project are open, Osisko said, adding that it will continue to monitor...
Akero Therapeutics Insider Sold Shares Worth $4,381,867, According to a Recent SEC Filing
Akero Therapeutics Insider Sold Shares Worth $4,381,867, According to a Recent SEC Filing
Jul 26, 2024
07:32 AM EDT, 07/26/2024 (MT Newswires) -- William Richard White, Chief Financial Officer, around July 23, 2024, sold 161,855 shares in Akero Therapeutics ( AKRO ) for $4,381,867. Following the Form 4 filing with the SEC, White has control over a total of 41,791 shares of the company, with 41,791 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1744659/000095017024086659/xslF345X03/ownership.xml ...
Booz Allen Hamilton Fiscal Q1 Adjusted Earnings Fall, Revenue Rises; Fiscal 2025 Outlook Reaffirmed
Booz Allen Hamilton Fiscal Q1 Adjusted Earnings Fall, Revenue Rises; Fiscal 2025 Outlook Reaffirmed
Jul 26, 2024
07:31 AM EDT, 07/26/2024 (MT Newswires) -- Booz Allen Hamilton Holding ( BAH ) reported fiscal Q1 adjusted earnings Friday of $1.38 per diluted share, down from $1.47 a year earlier. Analysts polled by Capital IQ expected $1.52. Revenue for the quarter ended June 30 was $2.94 billion, compared with $2.65 billion a year earlier. Analysts surveyed by Capital IQ...
Balchem's Q2 Earnings, Net Sales Rise
Balchem's Q2 Earnings, Net Sales Rise
Jul 26, 2024
07:32 AM EDT, 07/26/2024 (MT Newswires) -- Balchem ( BCPC ) reported Q2 adjusted earnings Friday of $1.09 per diluted share, up from $1.06 a year earlier. Two analysts surveyed by Capital IQ expected $1.04. Net sales for the quarter ended June 30 was $234.1 million, compared with $231.3 million a year earlier. Three analysts surveyed by Capital IQ expected...
Copyright 2023-2026 - www.financetom.com All Rights Reserved